Brian Cheng
Stock Analyst at J.P. Morgan
(4.16)
# 1,581
Out of 5,090 analysts
296
Total ratings
45.9%
Success rate
8%
Average return
Main Sectors:
Stocks Rated by Brian Cheng
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTCT PTC Therapeutics | Reiterated: Buy | $92 | $60.59 | +51.84% | 12 | Nov 2, 2026 | |
| XNCR Xencor | Maintained: Hold | n/a | $25.18 | - | 17 | Oct 27, 2026 | |
| TGTX TG Therapeutics | Maintained: Buy | n/a | $54.17 | - | 5 | Oct 27, 2026 | |
| TNGX Tango Therapeutics | Reiterated: Buy | n/a | $23.34 | - | 3 | Oct 23, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | n/a | $186.99 | - | 19 | Oct 21, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | n/a | $58.02 | - | 7 | Oct 15, 2026 | |
| ABSI Absci | Reiterated: Buy | $15 | $9.18 | +63.40% | 2 | Oct 12, 2026 | |
| AAPG Ascentage Pharma Group International | Reiterated: Buy | $46 → $33 | $15.44 | +113.73% | 7 | Oct 8, 2026 | |
| ABCL AbCellera Biologics | Initiated Coverage: Buy | $17 | $11.82 | +43.82% | 1 | Sep 29, 2026 | |
| KYMR Kymera Therapeutics | Reiterated: Buy | $140 | $110.76 | +26.40% | 9 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $76.78 | - | 2 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $14.63 | +105.06% | 3 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $36.49 | - | 27 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $28.22 | +16.94% | 14 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $149 | $138.43 | +7.64% | 24 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.25 | - | 9 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $7.26 | +299.45% | 5 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $0.8636 | - | 3 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $13 | $5.49 | +136.79% | 2 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $27 | $10.84 | +149.08% | 3 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $28.41 | +75.99% | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $29 | $19.60 | +47.96% | 2 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $24.05 | +82.95% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.33 | - | 5 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.99 | - | 9 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $5.39 | +438.03% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 | $11.21 | -28.64% | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $61.71 | +55.57% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $2.40 | - | 7 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $69 → $67 | $49.39 | +35.65% | 3 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.63 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $6.19 | n/a | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.44 | n/a | 8 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.01 | n/a | 1 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $6 | $0.8056 | n/a | 2 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $6 | $3.99 | n/a | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $0.1884 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $9.61 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $3.5 | $1.29 | n/a | 2 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $17 | $7.65 | n/a | 6 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.411 | n/a | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93 → $86 | $9.84 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.23 | n/a | 2 | Nov 2, 2021 |
PTC Therapeutics
Nov 2, 2026
Reiterated: Buy
Price Target: $92
Current: $60.59
Upside: +51.84%
Xencor
Oct 27, 2026
Maintained: Hold
Price Target: n/a
Current: $25.18
Upside: -
TG Therapeutics
Oct 27, 2026
Maintained: Buy
Price Target: n/a
Current: $54.17
Upside: -
Tango Therapeutics
Oct 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $23.34
Upside: -
Revolution Medicines
Oct 21, 2026
Reiterated: Buy
Price Target: n/a
Current: $186.99
Upside: -
Arrowhead Pharmaceuticals
Oct 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $58.02
Upside: -
Absci
Oct 12, 2026
Reiterated: Buy
Price Target: $15
Current: $9.18
Upside: +63.40%
Ascentage Pharma Group International
Oct 8, 2026
Reiterated: Buy
Price Target: $46 → $33
Current: $15.44
Upside: +113.73%
AbCellera Biologics
Sep 29, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $11.82
Upside: +43.82%
Kymera Therapeutics
Sep 28, 2026
Reiterated: Buy
Price Target: $140
Current: $110.76
Upside: +26.40%
Sep 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $76.78
Upside: -
Sep 23, 2026
Reiterated: Buy
Price Target: $30
Current: $14.63
Upside: +105.06%
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $36.49
Upside: -
Sep 3, 2026
Reiterated: Buy
Price Target: $33
Current: $28.22
Upside: +16.94%
Aug 31, 2026
Reiterated: Buy
Price Target: $149
Current: $138.43
Upside: +7.64%
Aug 17, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.25
Upside: -
Aug 17, 2026
Reiterated: Buy
Price Target: $29
Current: $7.26
Upside: +299.45%
Aug 17, 2026
Reiterated: Sell
Price Target: n/a
Current: $0.8636
Upside: -
Aug 12, 2026
Reiterated: Buy
Price Target: $10 → $13
Current: $5.49
Upside: +136.79%
Aug 10, 2026
Reiterated: Buy
Price Target: $31 → $27
Current: $10.84
Upside: +149.08%
Aug 10, 2026
Reiterated: Buy
Price Target: $50
Current: $28.41
Upside: +75.99%
Aug 10, 2026
Reiterated: Buy
Price Target: $26 → $29
Current: $19.60
Upside: +47.96%
Aug 6, 2026
Reiterated: Buy
Price Target: $44
Current: $24.05
Upside: +82.95%
Jun 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.33
Upside: -
Jun 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $17.99
Upside: -
May 13, 2026
Rated: Buy
Price Target: $29
Current: $5.39
Upside: +438.03%
May 13, 2026
Reiterated: Sell
Price Target: $8
Current: $11.21
Upside: -28.64%
May 11, 2026
Rated: Buy
Price Target: $96
Current: $61.71
Upside: +55.57%
Mar 13, 2026
Reiterated: Sell
Price Target: n/a
Current: $2.40
Upside: -
Feb 13, 2026
Reiterated: Buy
Price Target: $69 → $67
Current: $49.39
Upside: +35.65%
Nov 20, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $1.63
Upside: -
Aug 15, 2025
Upgraded: Hold
Price Target: n/a
Current: $6.19
Upside: n/a
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $1.44
Upside: n/a
Jul 15, 2024
Reiterated: Hold
Price Target: n/a
Current: $1.01
Upside: n/a
May 2, 2024
Downgraded: Hold
Price Target: $16 → $6
Current: $0.8056
Upside: n/a
Jun 1, 2023
Downgraded: Hold
Price Target: $20 → $6
Current: $3.99
Upside: n/a
Dec 16, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $0.1884
Upside: n/a
Dec 7, 2022
Downgraded: Sell
Price Target: n/a
Current: $9.61
Upside: n/a
Apr 19, 2022
Reiterated: Buy
Price Target: $33 → $3.5
Current: $1.29
Upside: n/a
Apr 8, 2022
Reiterated: Buy
Price Target: $21 → $17
Current: $7.65
Upside: n/a
Apr 4, 2022
Reiterated: Buy
Price Target: $12
Current: $0.411
Upside: n/a
Mar 1, 2022
Reiterated: Buy
Price Target: $93 → $86
Current: $9.84
Upside: n/a
Nov 2, 2021
Reiterated: Buy
Price Target: $14
Current: $1.23
Upside: n/a